• Home
  • E-submission
  • Sitemap
  • Contact us
  • Search
  • Advanced Search
Intest Res Search

CLOSE

‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).
The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Review

July 26, 2022


Endoscopic diagnosis and treatment of early colorectal cancer
Seung Wook Hong, Jeong-Sik Byeon
Intest Res. 2022;20(3):281-290.

Early colorectal cancer refers to cancer in the colorectum that is confined to the mucosa or submucosa and does not invade the muscularis propria, irrespective of lymph node or distant...

Review

January 7, 2022


Landscape of inflammatory bowel disease in Singapore
Daren Low, Nidhi Swarup, Toshiyuki Okada, et al.
Intest Res. 2022;20(3):291-296.

Inflammatory bowel disease (IBD), primarily Crohn’s disease and ulcerative colitis, had been widely recognized to affect the Western population. However, the notable rise in prevalence of IBD in Asia, including...

Original Article

August 4, 2021


Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease
Anthony Buisson, Lisa Cannon, Konstantin Umanskiy, et al.
Intest Res. 2022;20(3):303-312.

Background/Aims: We assessed the effectiveness of anti-TNF agents and its associated factors to prevent endoscopic and clinical postoperative recurrence (POR) in Crohn’s disease (CD). Methods: From a prospectively-maintained database, we...

Original Article

March 12, 2021


Risk factors for non-reaching of ileal pouch to the anus in laparoscopic restorative proctocolectomy with handsewn anastomosis for ulcerative colitis
Shigenobu Emoto, Keisuke Hata, Hiroaki Nozawa, et al.
Intest Res. 2022;20(3):313-320.

Background/Aims: Restorative proctocolectomy (RPC) with ileal pouch-anal anastomosis and handsewn anastomosis for ulcerative colitis requires pulling down of the ileal pouch into the pelvis, which can be technically challenging. We...

Original Article

July 20, 2021


Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease
Seung Hyuk Kim, You Sun Kim, Si Hyeong Lee, et al.
Intest Res. 2022;20(3):321-328.

Background/Aims: Nutritional status influences quality of life among patients with inflammatory bowel disease (IBD), although there is no clear method to evaluate nutritional status in this setting. Therefore, this study...

Original Article

August 4, 2021


Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, et al.
Intest Res. 2022;20(3):329-341.

Background/Aims: Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiated to evaluate its safety and effectiveness...

Original Article

May 21, 2021


A nationwide analysis on the influence of obesity in inflammatory bowel disease hospitalizations
Dushyant Singh Dahiya, Asim Kichloo, Farah Wani, et al.
Intest Res. 2022;20(3):342-349.

Background/Aims: Proinflammatory cytokines released from adipocytes can influence the development, progression, and treatment of inflammatory bowel disease (IBD), and may be associated with worse clinical outcomes. Methods: For 2016–2018, we...

Original Article

July 23, 2021


Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study
Seung Yong Shin, Soo Jung Park, Young Kim, et al.
Intest Res. 2022;20(3):350-360.

Background/Aims: This study assessed the efficacy and safety of adalimumab (ADA) and explored predictors of response in Korean patients with ulcerative colitis (UC). Methods: A prospective, observational, multicenter study was conducted...

Original Article

March 15, 2022


Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
José María Paredes, Tomás Ripollés, Ángela Algarra, et al.
Intest Res. 2022;20(3):361-369.

Background/Aims: Tight control of inflammation and adjustment of treatment if activity persists is the current strategy for the management of Crohn’s disease (CD). The usefulness of fecal calprotectin (FC) in...

Original Article

May 14, 2021


Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease
Shigeki Bamba, Osamu Inatomi, Atsushi Nishida, et al.
Intest Res. 2022;20(3):370-380.

Background/Aims: Crosstalk between the gut microbiota and bile acid plays an important role in the pathogenesis of gastrointestinal disorders. We investigated the relationship between microbial structure and bile acid metabolism...
Current Issue
Volume 20(3); Jul 2022
Prevention of postoperative recurrence in Crohn’s disease: the never-ending story
Jung-Bin Park, Sang Hyoung Park
Intest Res. 2022;20(3):279-280.

Editorial

Epub July 26, 2022
Endoscopic diagnosis and treatment of early colorectal cancer
Seung Wook Hong, Jeong-Sik Byeon
Intest Res. 2022;20(3):281-290.

Review

Epub July 26, 2022
Landscape of inflammatory bowel disease in Singapore
Daren Low, Nidhi Swarup, Toshiyuki Okada, et al.
Intest Res. 2022;20(3):291-296.

Review

Epub January 7, 2022
Endoscopy for assessment of mucosal healing in ulcerative colitis: time bound or response guided?
Ajit Sood, Ramit Mahajan, Arshdeep Singh, et al.
Intest Res. 2022;20(3):297-302.

Perspective

Epub February 8, 2022
Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease
Anthony Buisson, Lisa Cannon, Konstantin Umanskiy, et al.
Intest Res. 2022;20(3):303-312.

Original Article

Epub August 4, 2021
Risk factors for non-reaching of ileal pouch to the anus in laparoscopic restorative proctocolectomy with handsewn anastomosis for ulcerative colitis
Shigenobu Emoto, Keisuke Hata, Hiroaki Nozawa, et al.
Intest Res. 2022;20(3):313-320.

Original Article

Epub March 12, 2021
Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease
Seung Hyuk Kim, You Sun Kim, Si Hyeong Lee, et al.
Intest Res. 2022;20(3):321-328.

Original Article

Epub July 20, 2021
Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, et al.
Intest Res. 2022;20(3):329-341.

Original Article

Epub August 4, 2021
A nationwide analysis on the influence of obesity in inflammatory bowel disease hospitalizations
Dushyant Singh Dahiya, Asim Kichloo, Farah Wani, et al.
Intest Res. 2022;20(3):342-349.

Original Article

Epub May 21, 2021
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study
Seung Yong Shin, Soo Jung Park, Young Kim, et al.
Intest Res. 2022;20(3):350-360.

Original Article

Epub July 23, 2021
Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
José María Paredes, Tomás Ripollés, Ángela Algarra, et al.
Intest Res. 2022;20(3):361-369.

Original Article

Epub March 15, 2022
Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease
Shigeki Bamba, Osamu Inatomi, Atsushi Nishida, et al.
Intest Res. 2022;20(3):370-380.

Original Article

Epub May 14, 2021
Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis
Jim O’Connell, Jayne Doherty, Amy Buckley, et al.
Intest Res. 2022;20(3):381-385.

Brief Communication

Epub March 11, 2022
Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know
Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, et al.
Intest Res. 2022;20(3):386-388.

Letter to the Editor

Epub March 11, 2022
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD
ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2022 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next
Close layer
prev next